By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Entest Biomedical, Inc. 

San Diego  California    U.S.A.
Phone: n/a Fax:


Medical Device

Company News
Entest Biomedical, Inc. Recruits Salk Institute for Biological Studies Researcher To Lead Cancer Stem Cell Program For Treating Feline Leukemia And Canine Cancer 7/16/2014 10:31:26 AM
Entest Biomedical, Inc.'s ImenVax(TM) Cancer Vaccine Appears to Slow Tumor Growth in Advanced Canine Cancer Cases Without Hazardous Side Effects 9/6/2012 9:42:53 AM
Entest Biomedical, Inc. Sees Entry into $300 Million Veterinary Cancer Care Market Through Veterinary Hospital Acquisitions 9/4/2012 9:34:35 AM
Entest Biomedical, Inc. Excited With Progress on 10 Dog Pilot Study of "Universal Donor" Stem Cell Treatment for Canine Osteoarthritis 3/21/2012 8:48:08 AM
Entest Biomedical, Inc. Declares Dividend of Preferred Stock 2/13/2012 5:57:03 AM
Entest Biomedical, Inc. Launches Investor Relations Campaign 12/7/2011 6:42:36 AM
Entest Biomedical, Inc. Enters into Purchase Agreement With Oregon-Based Veterinary Hospital 11/8/2011 8:44:51 AM
Entest Biomedical, Inc. Signs Agreement With RenovoCyte and MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) for Pilot Study Using Universal Donor Stem Cells in Treatment of Dog Osteoarthritis 10/24/2011 9:54:00 AM
Entest Biomedical, Inc. Announces Promising Results From ImenVax(TM) Canine Cancer Vaccine Safety Study 7/28/2011 6:26:34 AM
Entest Biomedical, Inc. Unit Prepares to Enter the $58 Billion U.S. Pet Products Market by Establishing Online Veterinary Products Store 7/26/2011 9:07:55 AM